MedPath

remedē System Therapy Study

Active, not recruiting
Conditions
Central Sleep Apnea
Registration Number
NCT03884660
Lead Sponsor
Respicardia, Inc.
Brief Summary

The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.

Detailed Description

This is a multi-center, prospective, open label, non-randomized study to collect safety and effectiveness data in subjects with central sleep apnea implanted with the remedē System. Approximately 225 subjects will be enrolled and implanted at approximately 50 sites in the United States and Europe.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
225
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate safety of the remedē System at implant and protocol required follow up by assessment of serious adverse events (SAEs) related to procedure, device, or delivered therapy5 years

Proportion of subjects with peri-operative and long-term serious adverse events (SAEs) related to the remedē System implant procedure, device or delivered therapy

Evaluate changes in sleep disordered breathing metrics after 12 months of therapy12 months

Change from baseline to 12-month visit for the following sleep metrics measured during in-lab polysomnogram (PSG): apnea hypopnea index (AHI), central apnea index (CAI), oxygen desaturation index 4% (ODI4) and percent of sleep with oxygen saturation \<90%

Secondary Outcome Measures
NameTimeMethod
Evaluate safety of the remedē System by assessment of non-serious AE related to procedure, device or delivered therapy5 years

Proportion of subjects with non-serious AEs related to the remedē System implant procedure, device or delivered therapy

Evaluate changes in sleep disordered breathing metrics after 36 and 60 months of therapy36 and 60 months

Change from baseline to 36- and 60-month visits for the following sleep metrics during an at home sleep apnea test (HSAT): apnea hypopnea index (AHI), central apnea index (CAI), oxygen desaturation index 4% (ODI4), percent of sleep with oxygen saturation \<90%

Trial Locations

Locations (32)

Banner University Medical Center

🇺🇸

Phoenix, Arizona, United States

Arizona Heart Rhythm Center

🇺🇸

Phoenix, Arizona, United States

HonorHealth

🇺🇸

Scottsdale, Arizona, United States

The University of California San Francisco

🇺🇸

San Francisco, California, United States

University of Colorado- Anschutz

🇺🇸

Aurora, Colorado, United States

University of Colorado Health

🇺🇸

Fort Collins, Colorado, United States

Central Florida Pulmonary Group

🇺🇸

Orlando, Florida, United States

Emory University Midtown Hospital

🇺🇸

Atlanta, Georgia, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

Baptist Health Lexington

🇺🇸

Lexington, Kentucky, United States

University of Michigan Health West

🇺🇸

Wyoming, Michigan, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

St. Luke's Mid America Heart Institute

🇺🇸

Kansas City, Missouri, United States

The Valley Hospital

🇺🇸

Paramus, New Jersey, United States

New Mexico Heart Institute - Lovelace Medical Center

🇺🇸

Albuquerque, New Mexico, United States

Northwell Health

🇺🇸

New Hyde Park, New York, United States

New York Presbyterian Hospital-Weill Cornell Medicine

🇺🇸

New York, New York, United States

Novant Health - Charlotte

🇺🇸

Charlotte, North Carolina, United States

East Carolina University

🇺🇸

Greenville, North Carolina, United States

Novant Health Forsyth Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

The Ohio State Wexner Medical Center

🇺🇸

Columbus, Ohio, United States

Ohio Sleep Medicine Institute

🇺🇸

Dublin, Ohio, United States

Oklahoma Heart Institute

🇺🇸

Tulsa, Oklahoma, United States

Penn State Health Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

Amphia Longresearch

🇳🇱

Breda, Netherlands

Medisch Spectrum Twente

🇳🇱

Enschede, Netherlands

Monument Health

🇺🇸

Rapid City, South Dakota, United States

Baylor Scott and White - Dallas

🇺🇸

Dallas, Texas, United States

West Virginia University

🇺🇸

Morgantown, West Virginia, United States

OLVG Amsterdam

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath